Discover · The Research Behind It

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis — Nong et al., BMJ 2026

Last checked

  • Free
  • Worldwide
  • Research paper
  • Reading
  • Online
Published in
BMJ, 2026
Evidence
Strong
Cost
Free.

What is this paper about?

At one year, compared with lifestyle change alone, tirzepatide gave the most extra weight loss (14.9%), then cagrilintide-semaglutide (14.8%), oral semaglutide (10.9%), orforglipron (9.9%) and injected semaglutide (9.8%) (moderate to high certainty). Larger losses generally came with more side effects and stopping. Only injected semaglutide reduced deaths and heart attacks (mostly in trials of high-risk people), and no drug meaningfully improved quality of life.

Why is it in the directory?

Explains what modern weight-loss medicines can and cannot do, so readers can weigh them against the diet, fasting and exercise approaches in this directory (chapters 01, 10, 12 and 13) with their clinician.

Is it free to read?

Systematic review and network meta-analysis — 262 randomised trials, 99,791 adults, 19 drugs, GRADE. Strong evidence. BMJ 2026;394:e372161. Free full text at the publisher — open access, CC BY-NC 4.0.

About the paper

Authors
Nong K, Shi Q, Xie X, Wang Y, Agarwal A, Guyatt GH, et al.
Published in
BMJ 2026;394:e372161
Kind of study
Systematic review and network meta-analysis — 262 randomised trials, 99,791 adults, 19 drugs, GRADE
Strength of evidence
Strong — a consensus report, guideline or large body of trials points the same way
Free to read
CC BY-NC 4.0

Good to know

  • Follow-up ranged from 12 to 172 weeks, so long-term benefits and harms, especially of the newest drugs, remain uncertain.

Where it sits in the directory

Listed under “Metabolic Therapies — Fasting, Formula Diets, Ketogenic Therapy, Exercise, Surgery & Medicines” in chapter 17 of the directory, The Research Behind It, with 14 other listings in the same category.

See every listing in “Metabolic Therapies”

Similar listings

Also in the directory, with why each one is here.

Browse all 280 in The Research Behind It

This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.